AI MARKET SCANNING

Abbott Laboratories

AVG HISTORICAL GAP -0.82%
MAX GAP RECORD -10.93%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $ABT
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Oct 21, 2026 Earnings Release 2026-10-21 (BEFORE OPEN (08:00))
-1.11%
Jul 16, 2026 Earnings Release 2026-07-16 (BEFORE OPEN)
+6.74%
Apr 15, 2026 Earnings Release 2026-04-15 (AFTER CLOSE)
-4.36%
Jan 22, 2026 Earnings Release 2026-01-22 (BEFORE OPEN)
-10.93%
Oct 15, 2025 Earnings Release 2025-10-15 (BEFORE OPEN)
-3.52%
Jul 23, 2025 Earnings Release 2025-07-23 (BEFORE OPEN)
+0.58%
Apr 16, 2025 Earnings Release 2025-04-16 (BEFORE OPEN)
+2.76%
Jan 22, 2025 Earnings Release 2025-01-22 (BEFORE OPEN)
-2.28%

VOLATILITY & GAP BIAS

AVG GAP MOVE 3.1%
Bullish Gaps (4)
Bearish Gaps (9)
Neutral / Flat (3)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $ABT

EXECUTIONS1 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
2026-10-21 🔒 PRO RADAR ••• x• $•••.•• → $•••.•• 2600m +22.23%
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗